Atlanta, GACIK 20772471 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
23 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Acadia Pharmaceuticals Inc | 1.42M | $37.91M | 9.4% | +1.42M | New Position |
| 2 | Mind Medicine Mindmed Inc | 2.57M | $34.39M | 8.5% | +2.57M | New Position |
| 3 | Vaxcyte Inc | 737.5K | $34.03M | 8.4% | +737.5K | New Position |
| 4 |
| Nurix Therapeutics Inc |
| 1.74M |
| $33.07M |
| 8.2% |
| +1.74M |
| New Position |
| 5 | Lb Pharmaceuticals Inc | 1.40M | $31.07M | 7.7% | +1.40M | New Position |
| 6 | Xenon Pharmaceuticals Inc | 597.1K | $26.76M | 6.6% | +597.1K | New Position |
| 7 | Immunocore Hldgs PLC | 682.6K | $23.69M | 5.9% | +682.6K | New Position |
| 8 | Arcus Biosciences Inc | 916.3K | $21.84M | 5.4% | +916.3K | New Position |
| 9 | Tyra Biosciences Inc | 700.0K | $18.40M | 4.5% | +700.0K | New Position |
| 10 | Neurogene Inc | 785.0K | $16.17M | 4.0% | +785.0K | New Position |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio